Yahoo
OTC Markets OTCPK - Delayed Quote USD

Petros Pharmaceuticals, Inc. (PTPI)

0.0030 0.0000 (0.00%)
At close: November 6 at 4:00:00 PM EST
Chart Range Bar
Loading chart for PTPI
  • Previous Close 0.0030
  • Open 0.0028
  • Bid 0.0031 x 6180600
  • Ask 0.0034 x 3000000
  • Day's Range 0.0028 - 0.0034
  • 52 Week Range 0.0020 - 0.0220
  • Volume 87,526
  • Avg. Volume 142,520
  • Market Cap (intraday) 127,116
  • Beta (5Y Monthly) 2.17
  • PE Ratio (TTM) 0.04
  • EPS (TTM) 0.0800
  • Earnings Date --
  • Forward Dividend & Yield -- (0.00%)
  • 1y Target Est --
  • Moby Rating Neutral

Petros Pharmaceuticals, Inc., a healthcare technology company, focuses on developing and licensing proprietary software as a service (SaaS) platform and Software as a medical device web application designed to assist pharmaceutical companies. The company is based in New York, New York.

petrospharma.com

3

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 11/6/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

PTPI
62.50%
S&P 500 (^GSPC)
7.76%

1-Year Return

PTPI
84.21%
S&P 500 (^GSPC)
9.77%

3-Year Return

PTPI
99.99%
S&P 500 (^GSPC)
68.96%

5-Year Return

PTPI
100.00%
S&P 500 (^GSPC)
57.04%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q3 FY24
Revenue 1.58M
Earnings -5.25M
Profit Margin -332.84%

Q4

FY23

Q1

FY24

Q2

FY24

Q3

FY24

-8M
-6M
-4M
-2M
0
-500.0%
0.0%
500.0%
1000.0%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -38.81%

  • Return on Equity (ttm)

    -124.40%

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -17.36M

  • Diluted EPS (ttm)

    0.0800

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    3.49M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -1.82M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: